USEUROPEAFRICAASIA 中文双语Français
Business
Home / Business / Companies

Fosun Pharmaceutical acquires Israeli aesthetic device company

By LIU JIE | chinadaily.com.cn | Updated: 2013-05-30 14:22

Shanghai Fosun Pharma (Group) Ltd announced on Monday that it has acquired a 95.2 percent stake in Israel-based Alma Lasers Ltd for $221 million.

Set up in 1999, Alma Lasers is a developer and manufacturer of laser, light-based, radio-frequency and ultrasound products with integrated product portfolios for aesthetic and medical applications.

It accounts for 15 percent of the global high-end aesthetic devices market.

Fosun Pharma said it made the investment together with its subsidiary Pramerica-Fosun China Opportunity Fund, a US-dollar denominated investment fund.

According to Chen Qiyu, chairman of Fosun Pharma, the Chinese medical giant is confident in the growth of the global aesthetics industry, especially in China, Brazil, Russia and India.

"We will continue to support the global business development of Alma Lasers," he said, adding that Fosun Pharma will establish Alma Lasers as a management platform for research and development, manufacturing and sales of high-end medical devices, providing an internationalized development path for the company.

Most Viewed in 24 Hours
BACK TO THE TOP
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US